Compare CP & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CP | MDT |
|---|---|---|
| Founded | 1881 | 1949 |
| Country | Canada | Ireland |
| Employees | N/A | N/A |
| Industry | Railroads | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.0B | 107.0B |
| IPO Year | 2000 | 2014 |
| Metric | CP | MDT |
|---|---|---|
| Price | $91.92 | $90.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 21 |
| Target Price | $93.67 | ★ $108.21 |
| AVG Volume (30 Days) | 2.7M | ★ 6.7M |
| Earning Date | 04-29-2026 | 06-03-2026 |
| Dividend Yield | 0.79% | ★ 3.58% |
| EPS Growth | ★ 13.32 | 3.32 |
| EPS | 2.10 | ★ 3.73 |
| Revenue | $15,078,000,000.00 | ★ $36,364,000,000.00 |
| Revenue This Year | $8.71 | $8.91 |
| Revenue Next Year | $6.15 | $6.54 |
| P/E Ratio | $43.77 | ★ $24.31 |
| Revenue Growth | 3.66 | ★ 8.43 |
| 52 Week Low | $68.42 | $73.31 |
| 52 Week High | $93.95 | $106.33 |
| Indicator | CP | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 55.36 | 63.12 |
| Support Level | $83.55 | $85.35 |
| Resistance Level | $93.95 | $105.92 |
| Average True Range (ATR) | 2.00 | 1.97 |
| MACD | -0.03 | 0.35 |
| Stochastic Oscillator | 80.48 | 79.21 |
Canadian Pacific Kansas City is a Class I railroad operating on tracks that span most of Canada and into parts of the Midwestern and Northeastern United States. Following the April 2023 Kansas City Southern merger, CPKC operates new single-linehaul services from Canada and the Upper Midwest down through Texas, the Gulf of Mexico, and into Mexico. It also hauls cross-border and intra-Mexico freight via operating concessions on more than 3,000 miles of rail in Mexico. CPKC hauls shipments of grain, intermodal containers, energy products (like crude and frac sand), chemicals, plastics, coal, fertilizer and potash, automotive products, and a diverse mix of other merchandise.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.